Hospital @ Home Model of Care for Cirrhosis

Recruiting now · Not applicable

Conditions studied: Decompensated Cirrhosis

In brief

The purpose of this study is to work with patients diagnosed with end-stage liver disease to understand their perspectives on the Health at Home (H@H) Program, including desired outcomes and expectations, perceived barriers, and drivers. H@H is an emerging model of home-based care, designed to extend traditional, inpatient hospital care which may address these needs. Through H@H, acute medical care services as well as ancillary care such as rehabilitation therapy can be delivered in the home. The study is divided into three phases: Phase 1 occurs while the participant is an inpatient. Phase 2 is when the actual H@H program takes place as part of the participant's clinical care. The study team will not be involved in the Phase 2 - H@H program as it will be conducted by the clinical staff. Phase 3, at which point the participant enters a rehabilitation phase to transition the patient to self-management, involves a research jam session with the participant and caregiver to assess the value of the program.

Key facts

Study ID

NCT06396897

Run by

Indiana University

People needed

30

Starts

2024-05-10

Expected to finish

2026-12-31

Last updated by the study team

2026-07-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Enrolled into IUH's H@H program
• At least 18 years of age
• Chronic liver disease/cirrhosis based on characteristic clinical, laboratory, and imaging findings
• English speaking
• Able to provide consent
• Caregiver able to be present during the acute phase of care (first 48 hours post-hospital discharge)
• Able to perform activities of daily living independently
• Lives within IU Health Home service area

You may not qualify if…

• Unable to complete study questionnaires due to neurocognitive disease, legal blindness or hearing loss
• Transplant of organ other than liver
• Pregnant
• Incarcerated
• New hemodialysis
• Blood pressure < 90/60, Pulse > 120, O2 > 6L or >2L above baseline
• HIV+/CD4 count < 200
• Receiving hospice services
• Concurrent enrollment in a related research study

Where it is running

• IU School of Medicine — Indianapolis, Indiana, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.